Tuberculosis in a Multiethnic Inner City Population
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
To determine the incidence of tuberculosis in an inner city population, identify risk factors for TB, describe the natural history in adults and children, evaluate the effect of Mycobacterium tuberculosis (Mtb) co-infection on the progression of human immunodeficiency virus disease, and determine factors that contribute to compliance and non-compliance with prophylaxis and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 1994
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 1994
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 1999
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 1999
CompletedFirst Submitted
Initial submission to the registry
May 25, 2000
CompletedFirst Posted
Study publicly available on registry
May 26, 2000
CompletedDecember 29, 2015
December 1, 2015
4.9 years
May 25, 2000
December 28, 2015
Conditions
Study Arms (3)
IV drug users and their sexual contacts
This group will be made up of an already-recruited cohort
Children who receive primary care at Bellevue Hospital
Bellevue Hospital inpatients/outpatients
Inpatients being treated for TB and outpatients receiving prophylactic treatment
Eligibility Criteria
The study population will be made up of three cohorts: (1) intravenous drug users and their sexual contacts in an already-recruited cohort; (2) children who receive their primary care at Bellevue Hospital Medical Center; and (3) Bellevue Hospital Center inpatients with TB and outpatients undergoing prophylactic treatment
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Related Publications (3)
Wolfe H, Marmor M, Maslansky R, Nichols S, Simberkoff M, Des Jarlais D, Moss A. Tuberculosis knowledge among New York City injection drug users. Am J Public Health. 1995 Jul;85(7):985-8. doi: 10.2105/ajph.85.7.985.
PMID: 7604926BACKGROUNDDavidow AL, Marmor M, Alcabes P. Geographic diversity in tuberculosis trends and directly observed therapy, New York City, 1991 to 1994. Am J Respir Crit Care Med. 1997 Nov;156(5):1495-500. doi: 10.1164/ajrccm.156.5.96-12078.
PMID: 9372666BACKGROUNDDavidow AL, Alcabes P, Marmor M. The contribution of recently acquired Mycobacterium tuberculosis infection to the New York City tuberculosis epidemic, 1989-1993. Epidemiology. 2000 Jul;11(4):394-401. doi: 10.1097/00001648-200007000-00006.
PMID: 10874545BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Marmor
NYU Langone Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2000
First Posted
May 26, 2000
Study Start
August 1, 1994
Primary Completion
July 1, 1999
Study Completion
July 1, 1999
Last Updated
December 29, 2015
Record last verified: 2015-12